Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus plus Imatinib in Resistant GIST
NCT00510354Phase 4Completed
- Sponsor
- Novartis
- Start
- Oct 2006
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in gastrointestinal stromal tumor (GIST), sponsored by Novartis. Started Oct 2006; status: completed.
02
Drugs
everolimus
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00510354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00510354.